CARD, Lineagen Offering ASD Test | GenomeWeb

NEW YORK (GenomeWeb News) – The Center for Autism and Related Disorders and molecular diagnostics firm Lineagen today announced a partnership to offer the FirstStep genetic test to patients.

Lineagen's whole-genome genetic test for autism spectrum disorders will be integrated with pre- and post-genetic counseling services and personalized reporting and will be available to patients in CARD's Skills program. The program is designed to meet clinical guidelines recommending chromosomal microarray analysis as a first-line genetic test to evaluate individuals with ASD.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.